39 completed, 29 unknown, 10 terminated, 9 recruiting. 97 Phase 3, 21 Phase 2.
Follow Control Group: new trials by email Literature Review of Control Group trials Research Report on Control Group
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Clinical Trial of DN022150 Combined With AG Chemotherapy as First-line Treatment for Locally Advanced or Metastatic Pancreatic Cancer With KRAS G12D Mutation DN022150+AG( Stage I ）, DN022150+AG（Stage II）, placebo+AG（Stage II） - Pancreatic Cancer, Pancreatic Carcinoma | Phase 2 / Phase 3 | Not yet recruiting | Jiangxi Kvvit Pharmaceutical Co., Ltd. | 465 | 2027-06-06 | 2026-06-18 |
| Chidamide Maintenance to Prevent Relapse After Allogeneic Hematopoietic Stem Cell Transplantation in Acute T-Lymphoblastic Leukemia/Lymphoma Chidamide, Control Group - T-Cell Acute Lymphoblastic Leukemia, T-Cell Lymphoblastic Lymphoma | Phase 3 | Not yet recruiting | First Affiliated Hospital of Zhejiang University | 132 | 2026-08-15 | 2026-08-19 |
| Effect of Epidural Needle Injection on Catheter Placement Success During Painless Labour Injection Group, Control group - Labour Analgesia | Phase 3 | Not yet recruiting | Al-Azhar University | 216 | 2026-06-28 | 2026-01-08 |
| Melatonin vs Midazolam in Children Undergoing Tonsillectomy Melatonin group, Midazolam group, Control group - Emergence Delirium, Anesthesia, Child | Phase 3 | Not yet recruiting | Ain Shams University | 195 | 2026-03-01 | 2026-01-13 |
| Efficacy and Safety Comparison of Short-course Radiotherapy Followed by CapeOX Chemotherapy Plus Toripalimab With or Without Concurrent Surufatinib in Neoadjuvant Therapy for Mid-to-low Localized Rectal Cancer of High-risk Criteria Experimental Group, Control group - Rectal Cancer | Phase 2 / Phase 3 | Recruiting | The First Hospital of Jilin University | 212 | 2026-02-23 | 2026-04-01 |
| Effects of Butylphthalide Enhanced With Tenecteplase on Neurological Function in Mild Disabling Acute Ischemic Stroke Combination Group, Control Group - Mild Disabling Acute Ischemic Stroke | Phase 3 | Recruiting | Xiangya Hospital of Central South University | 1062 | 2026-02-01 | 2026-08-03 |
| Gluma Compared With Bonding Agent for Post-operative Sensitivity Following Composite Restorations Drug/Agent: Gluma Desensitizer, Drug/Agent: No desensitizer (Control) - Post-operative Sensitivity, Dentin Hypersensitivity | Phase 2 / Phase 3 | Not yet recruiting | Beenish Hassan | 60 | 2025-12-01 | 2025-09-23 |
| Growth Hormone and Dehydroepiandrosterone Role in Vitro Fertilization Somatropin (4IU for 1 month) plus, folic acid 400 mcg per day., DHEA plus folic acid 400mcg per day, control group - Infertility, Infertility (IVF Patients) | Phase 2 / Phase 3 | Recruiting | Beni-Suef University | 165 | 2025-10-10 | 2026-01-07 |
| Role of Non-Selective Beta-Adrenergic Blocker in Severe TBI propranolol, normal saline IV - Traumatic Brain Injury (TBI) Patients, Intracranial Pressure | Phase 3 | Not yet recruiting | Tanta University | 60 | 2025-09-20 | 2025-03-11 |
| Bevacizumab-based Chemotherapy Adapted to Bevacizumab Pharmacokinetics in 1st-line Treatment Avastin, 25 Mg/mL Intravenous Solution - Unresectable Metastatic Colorectal Cancer | Phase 3 | Recruiting | University Hospital, Tours | 244 | 2025-03-04 | 2026-06-16 |
| A Phase Ⅲ Clinical Trial of Recombinant COVID-19 Trivalent (XBB+BA.5+Delta) Protein Vaccine (Sf9 Cell) in Booster Vaccination High dose of Recombinant COVID-19 Trivalent (XBB+BA.5+Delta) Protein Vaccine (Sf9 Cell), Low dose of Recombinant COVID-19 Trivalent (XBB+BA.5+Delta) Protein Vaccine (Sf9 Cell), control group - COVID-19 | Phase 3 | Unknown | WestVac Biopharma Co., Ltd. | 4950 | 2024-12-30 | 2024-07-25 |
| Regular Physical Exercise in Patients With Symptomatic Intracranial Arterial Stenosis Regular physical exercise, Control group - Ischemic Stroke, Transient Ischemic Attack | Phase 3 | Active not recruiting | Capital Medical University | 1300 | 2024-10-10 | 2025-11-25 |
| Evaluation of the Role of N Acetyl Cysteine and Vitamin D in Improving Outcomes After Corrosive Ingestion N Acetyl Cysteine, Vitamin D (Cholecalciferol ), control group - Corrosive Injury | Phase 3 | Active not recruiting | Ain Shams University | 80 | 2024-10-01 | 2025-11-17 |
| Efficacy and Safety of Tacrolimus in Combination With Ripertamab in the Initial Treatment of Patients With MCD Supportive care+Prednisone, Supportive care+Tacrolimus+Ripertamab, Supportive care+Ripertamab - Minimal Change Disease | Phase 3 | Not yet recruiting | Air Force Military Medical University, China | 81 | 2024-05-01 | 2024-05-08 |
| a Multicentre Phase III Study of Risk-based Treatment Intensification With Hyperfractionated Radiotherapy in Head and Neck Cancer Patients Hyperfractionated radiotherpy, Control group - Head and Neck Squamous Cell Carcinoma | Phase 3 | Recruiting | Lund University Hospital | 308 | 2024-03-04 | 2024-09-19 |
| Function of Tamsulosin in Older Males Undergoing Surgery With Indwelling Catheter Tamsulosin, Control Group - Postoperative Urinary Tract Infection | Phase 3 | Completed | Emory University | 87 | 2024-02-26 | 2026-04-09 |
| Efficacy and Safety of AJU-S56 5% in Dry Eye Syndrome Patients AJU-S56 5%, Placebo Group(Vehicle) - Dry Eye Syndromes | Phase 3 | Unknown | AJU Pharm Co., Ltd. | 396 | 2023-11-10 | 2024-04-08 |
| A Phase 3 Clinical Trials for Bowel Preparation for Colonoscopy CTP0302-A, CTP0302-B, Conventional OST - Bowel Preparation | Phase 3 | Completed | Taejoon Pharmaceutical Co., Ltd. | 161 | 2023-08-29 | 2024-11-29 |
| PROpranolol for Cerebral Hemorrhage-ASsociated pnEumonia (PRO-CHASE) Propranolol Hydrochloride, control group - Stroke, Vascular Accident | Phase 2 / Phase 3 | Completed | Beijing Tiantan Hospital | 168 | 2023-02-21 | 2025-07-14 |
| Perampanel in Focal Status Epilepticus Perampanel, Placebo - Epilepticus; Status, Focal Motor | Phase 3 | Terminated | Assistance Publique - Hôpitaux de Paris | 1 | 2022-11-02 | 2023-12-14 |
Showing 20 of 97. Sign in to see all of them.
Infertility (5) · COVID-19 (4) · Breast Neoplasms (3) · Stroke (3) · Abdominal Pain (2) · Glaucoma, Open-Angle (2) · Infections (2) · Inflammation (2) · Nausea (2) · Ocular Hypertension (2) · Pain, Postoperative (2) · Shoulder Pain (2) · Uterine Cervical Neoplasms (2) · Abdominal obesity metabolic syndrome (1) · Acute Kidney Injury (1)
Assistance Publique - Hôpitaux de Paris (4) · Forest Laboratories (3) · Ain Shams University (2) · Glaukos Corporation (2) · Guiyang Medical University (2) · Taipei Veterans General Hospital, Taiwan (2) · Universitas Indonesia (2) · AJU Pharm Co., Ltd. (1) · Administracion Nacional de Laboratorios e Institutos de Salud Dr. Carlos G. Malbran (1) · Agiad Psychiatry Hospital (1) · Air Force Military Medical University, China (1) · Al-Azhar University (1) · All India Institute of Medical Sciences (1) · Asociación para Evitar la Ceguera en México (1) · Assiut University (1)
France (12) · United States (12) · China (11) · Egypt (10) · Taiwan (4) · Belgium (3) · Indonesia (3) · South Korea (3) · Brazil (2) · Colombia (2) · India (2) · Israel (2) · Mexico (2) · Pakistan (2) · Spain (2)
Tennador Sanderson (3) · Hsiao-Wen Tsai, M.D. (2) · Yuanyuan Li, Master (2) · Ade Meidian Ambari, MD,FIHA (1) · Ahmed A. Dobie, Msc. (1) · Ahmed Deebis, MD (1) · Anders B. Gottlieb Hansen, cand.techn.soc (1) · Anthony R Carlini, MS (1) · Arlene M Butz, SCD,MSN,BSN (1) · Carlos Tene, DS (1) · Caroline Petorin (1) · Christine M Olson, PhD (1) · Christophe Borg (1)
PMID 38985408, PMID 39240530, PMID 10990106, PMID 15371767, PMID 16106006, PMID 16306743, PMID 16439323, PMID 17043939, PMID 18448749, PMID 19500403, PMID 21204265, PMID 21804697, PMID 21949192, PMID 22184293, PMID 22824930, PMID 22914044, PMID 22983833, PMID 23045575, PMID 23291734, PMID 2339953, PMID 23635614, PMID 24108780, PMID 24431901, PMID 24523666, PMID 24964084, PMID 25107877, PMID 25143156, PMID 25313566, PMID 25733629, PMID 25957183, PMID 26386503, PMID 28069560, PMID 28284834, PMID 28573669, PMID 29105516, PMID 29743026, PMID 30072155, PMID 30525951, PMID 30971235, PMID 30992044, PMID 31278924, PMID 31307503, PMID 3178353, PMID 31980156, PMID 31986264, PMID 32020029, PMID 32346093, PMID 32690074, PMID 33790861, PMID 33981417
2014 (1), 2015 (1), 2018 (1), 2019 (1), R01HD105678 (1), R01NR005062 (1)